mortality/aging
• loss of Dok1 shortened lifespan to about 307 days from about 325 days in mice that are hemizygous for Tg(BCR/ABL1)5Hhi and wild-type for Dok1
|
neoplasm
• inactivation of Dok1 accelerated the onset of the chronic phase and the fatal blastic phase
• acceleration was not as severe as in homozygous null mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chronic myeloid leukemia | DOID:8552 |
OMIM:608232 |
J:95334 |